Glioblastoma (GB) is one of the most aggressive brain tumors. These tumors modify their metabolism, increasing the expression of glucose transporters, GLUTs, which incorporate glucose and the oxidized form of vitamin C, dehydroascorbic acid (DHA). We hypothesized that GB cells preferentially take up DHA, which is intracellularly reduced and compartmentalized into the endoplasmic reticulum (ER), promoting collagen biosynthesis and an aggressive phenotype.
Results:
Our results showed that GB cells take up DHA using GLUT1, while GLUT3 and sodium-dependent vitamin C transporter 2 (SVCT2) are preferably intracellular. Using a baculoviral system and reticulum-enriched extracts, we determined that SVCT2 is mainly located in the ER and corresponds to a short isoform. Ascorbic acid (AA) was compartmentalized, stimulating collagen IV secretion and increasing in vitro and in situ cell migration. Finally, orthotopic xenografts induced in immunocompetent guinea pigs showed that vitamin C deficiency retained collagen, reduced blood vessel invasion, and affected glomeruloid vasculature formation, all pathological conditions associated with malignancy.
Innovation and Conclusion:
We propose a functional role for vitamin C in GB development and progression. Vitamin C is incorporated into the ER of GB cells, where it favors the synthesis of collagen, thus impacting tumor development. Collagen secreted by tumor cells favors the formation of the glomeruloid vasculature and enhances perivascular invasion. Antioxid. Redox Signal. 37, 538–559.
Get full access to this article
View all access options for this article.
References
1.
AlievaM, LeidgensV, RiemenschneiderMJ, KleinCA, HauP, and van RheenenJ. Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion. Sci Rep, 9: 2054, 2019.
2.
BoadoRJ, BlackKL, and PardridgeWM. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res Mol Brain Res, 27: 51–57, 1994.
3.
CarroMS, LimWK, AlvarezMJ, BolloRJ, ZhaoX, SnyderEY, SulmanEP, AnneSL, DoetschF, ColmanH, LasorellaA, AldapeK, CalifanoA, and IavaroneA. The transcriptional network for mesenchymal transformation of brain tumours. Nature, 463: 318–325, 2010.
ChenJ, MaoS, LiH, ZhengM, YiL, LinJM, and LinZX. The pathological structure of the perivascular niche in different microvascular patterns of glioblastoma. PLoS One, 12: e0182183, 2017.
6.
ChenLY, LinB, PanCJ, HiraiwaH, and ChouJY. Structural requirements for the stability and microsomal transport activity of the human glucose 6-phosphate transporter. J Biol Chem, 275: 34280–34286, 2000.
7.
ChenQ, EspeyMG, SunAY, PooputC, KirkKL, KrishnaMC, KhoshDB, DriskoJ, and LevineM. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A, 105: 11105–11109, 2008.
8.
ChengYX, XiaoL, YangYL, LiuXD, ZhouXR, BuZF, CaoPC, and WangDK. Collagen type VIII alpha 2 chain (COL8A2), an important component of the basement membrane of the corneal endothelium, facilitates the malignant development of glioblastoma cells via inducing EMT. J Bioenerg Biomembr, 53: 49–59, 2021.
9.
ChintalaSK, GokaslanZL, GoY, SawayaR, NicolsonGL, and RaoJS. Role of extracellular matrix proteins in regulation of human glioma cell invasion in vitro. Clin Exp Metastasis, 14: 358–366, 1996.
10.
ChoS, ChaeJS, ShinH, ShinY, SongH, KimY, YooBC, RohK, ChoS, KilEJ, ByunHS, ChoSH, ParkS, LeeS, and YeomCH. Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression. Sci Rep, 8: 11372, 2018.
11.
ChungK, WallaceJ, KimSY, KalyanasundaramS, AndalmanAS, DavidsonTJ, MirzabekovJJ, ZalocuskyKA, MattisJ, DenisinAK, PakS, BernsteinH, RamakrishnanC, GrosenickL, GradinaruV, and DeisserothK. Structural and molecular interrogation of intact biological systems. Nature, 497: 332–337, 2013.
12.
CimminoL, NeelBG, and AifantisI. Vitamin C in stem cell reprogramming and cancer. Trends Cell Biol, 28: 698–708, 2018.
13.
CossetE, IlmjarvS, DutoitV, ElliottK, von SchalschaT, CamargoMF, ReissA, MoroishiT, SeguinL, GomezG, MooJS, Preynat-SeauveO, KrauseKH, ChneiweissH, SarkariaJN, GuanKL, DietrichPY, WeisSM, MischelPS, and ChereshDA. Glut3 Addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma. Cancer Cell, 32: 856–868 e5, 2017.
14.
CuddapahVA, RobelS, WatkinsS, and SontheimerH. A neurocentric perspective on glioma invasion. Nat Rev Neurosci, 15: 455–465, 2014.
15.
D'AnielloC, CermolaF, PalamidessiA, WanderlinghLG, GagliardiM, MigliaccioA, VarroneF, CasalinoL, MatarazzoMR, De CesareD, ScitaG, PatriarcaEJ, and MinchiottiG. Collagen prolyl hydroxylation-dependent metabolic perturbation governs epigenetic remodeling and mesenchymal transition in pluripotent and cancer cells. Cancer Res, 79: 3235–3250, 2019.
16.
de GooijerMC, Guillen NavarroM, BernardsR, WurdingerT, and van TellingenO. An experimenter's guide to glioblastoma invasion pathways. Trends Mol Med, 24: 763–780, 2018.
17.
EcheverriaC, NualartF, FerradaL, SmithGJ, and GodoyAS. Hexose transporters in cancer: from multifunctionality to diagnosis and therapy. Trends Endocrinol Metab, 32: 198–211, 2021.
18.
FerradaL, BarahonaMJ, SalazarK, VandenabeeleP, and NualartF. Vitamin C controls neuronal necroptosis under oxidative stress. Redox Biol, 29: 101408, 2020.
19.
FerradaL, SalazarK, and NualartF. Metabolic control by dehydroascorbic acid: questions and controversies in cancer cells. J Cell Physiol, 234: 19331–19338, 2019.
FuJ, WuZ, LiuJ, and WuT. Vitamin C: a stem cell promoter in cancer metastasis and immunotherapy. Biomed Pharmacother, 131: 110588, 2020.
22.
GarciaC, DuboisLG, XavierAL, GeraldoLH, da FonsecaAC, CorreiaAH, MeirellesF, VenturaG, RomaoL, CanedoNH, de SouzaJM, de MenezesJR, Moura-NetoV, Tovar-MollF, and LimaFR. The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model. BMC Cancer, 14: 923, 2014.
23.
Garcia-KraussA, FerradaL, AstuyaA, SalazarK, CisternasP, MartinezF, RamirezE, and NualartF. Dehydroascorbic acid promotes cell death in neurons under oxidative stress: a protective role for astrocytes. Mol Neurobiol, 53: 5847–5863, 2016.
GodoyA, OrmazabalV, Moraga-CidG, ZunigaFA, SotomayorP, BarraV, VasquezO, MontecinosV, MardonesL, GuzmanC, VillagranM, AguayoLG, OnateSA, ReyesAM, CarcamoJG, RivasCI, and VeraJC. Mechanistic insights and functional determinants of the transport cycle of the ascorbic acid transporter SVCT2. Activation by sodium and absolute dependence on bivalent cations. J Biol Chem, 282: 615–624, 2007.
26.
GrassoC, FabreMS, CollisSV, CastroML, FieldCS, SchleichN, McConnellMJ, and HerstPM. Pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model. Front Oncol, 4: 356, 2014.
27.
HanJ and DanielJC. Biosynthesis of type VI collagen by glioblastoma cells and possible function in cell invasion of three-dimensional matrices. Connect Tissue Res, 31: 161–170, 1995.
28.
HeaneyML, GardnerJR, KarasavvasN, GoldeDW, ScheinbergDA, SmithEA, and O'ConnorOA. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res, 68: 8031–8038, 2008.
29.
JaraN, CifuentesM, MartinezF, SalazarK, and NualartF. Cytoarchitecture, proliferative activity and neuroblast migration in the subventricular zone and lateral ventricle extension of the adult guinea pig brain. Stem Cells, 34: 2574–2586, 2016.
30.
JaraN, RamirezE, FerradaL, SalazarK, EspinozaF, Gonzalez-ChavarriaI, and NualartF. Vitamin C deficient reduces proliferation in a human periventricular tumor stem cell-derived glioblastoma model. J Cell Physiol, 236: 5801–5817, 2021.
31.
KampaJM, KellnerU, MarschingC, Ramallo GuevaraC, KnappeUJ, SahinM, GiampaM, NiehausK, and BednarzH. Glioblastoma multiforme: metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging. Neuropathology, 40: 546–558, 2020.
32.
KimEJ, ParkYG, BaikEJ, JungSJ, WonR, NahmTS, and LeeBH. Dehydroascorbic acid prevents oxidative cell death through a glutathione pathway in primary astrocytes. J Neurosci Res, 79: 670–679, 2005.
33.
KuiperC and VissersMC. Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol, 4: 359, 2014.
34.
LinJ, JiangL, WangX, WeiW, SongC, CuiY, WuX, and QiuG. P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway. J Oncol, 2021: 1406853, 2021.
35.
LouisDN, PerryA, ReifenbergerG, von DeimlingA, Figarella-BrangerD, CaveneeWK, OhgakiH, WiestlerOD, KleihuesP, and EllisonDW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol, 131: 803–820, 2016.
36.
LutsenkoEA, CarcamoJM, and GoldeDW. A human sodium-dependent vitamin C transporter 2 isoform acts as a dominant-negative inhibitor of ascorbic acid transport. Mol Cell Biol, 24: 3150–3156, 2004.
37.
LvH, WangC, FangT, LiT, LvG, HanQ, YangW, and WangH. Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2. NPJ Precis Oncol, 2: 1, 2018.
38.
MahesparanR, TysnesBB, ReadTA, EngerPO, BjerkvigR, and Lund-JohansenM. Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro. Acta Neuropathol, 97: 231–239, 1999.
39.
MammotoT, JiangA, JiangE, PanigrahyD, KieranMW, and MammotoA. Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am J Pathol, 183: 1293–1305, 2013.
40.
MataJM, AssadR, and PeterkofskyB. An intramembranous reductant which participates in the proline hydroxylation reaction with intracisternal prolyl hydroxylase and unhydroxylated procollagen in isolated microsomes from L-929 cells. Arch Biochem Biophys, 206: 93–104, 1981.
41.
MoeckelS, MeyerK, LeukelP, HeudorferF, SeligerC, StanglC, BogdahnU, ProescholdtM, BrawanskiA, Vollmann-ZwerenzA, RiemenschneiderMJ, BosserhoffAK, SpangR, and HauP. Response-predictive gene expression profiling of glioma progenitor cells in vitro. PLoS One, 9: e108632, 2014.
42.
Munoz-MontesinoC, RoaFJ, PenaE, GonzalezM, SotomayorK, InostrozaE, MunozCA, GonzalezI, MaldonadoM, SolizC, ReyesAM, VeraJC, and RivasCI. Mitochondrial ascorbic acid transport is mediated by a low-affinity form of the sodium-coupled ascorbic acid transporter-2. Free Radic Biol Med, 70: 241–254, 2014.
43.
MunroS and PelhamHR. A C-terminal signal prevents secretion of luminal ER proteins. Cell, 48: 899–907, 1987.
44.
MuradS, GroveD, LindbergKA, ReynoldsG, SivarajahA, and PinnellSR. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci U S A, 78: 2879–2882, 1981.
45.
MyllylaR, Kuutti-SavolainenER, and KivirikkoKI. The role of ascorbate in the prolyl hydroxylase reaction. Biochem Biophys Res Commun, 83: 441–448, 1978.
46.
NagamatsuS, SawaH, WakizakaA, and HoshinoT. Expression of facilitative glucose transporter isoforms in human brain tumors. J Neurochem, 61: 2048–2053, 1993.
NgoB, Van RiperJM, CantleyLC, and YunJ. Targeting cancer vulnerabilities with high-dose vitamin C. Nat Rev Cancer, 19: 271–282, 2019.
49.
NualartFJ, RivasCI, MontecinosVP, GodoyAS, GuaiquilVH, GoldeDW, and VeraJC. Recycling of vitamin C by a bystander effect. J Biol Chem, 278: 10128–10133, 2003.
50.
OgawaK, OguchiM, NakashimaY, and YamabeH. Distribution of collagen type IV in brain tumors: an immunohistochemical study. J Neurooncol, 7: 357–366, 1989.
51.
PadayattySJ and LevineM. Vitamin C: the known and the unknown and Goldilocks. Oral Dis, 22: 463–493, 2016.
52.
PastorP, CisternasP, SalazarK, Silva-AlvarezC, OyarceK, JaraN, EspinozaF, MartinezAD, and NualartF. SVCT2 vitamin C transporter expression in progenitor cells of the postnatal neurogenic niche. Front Cell Neurosci, 7: 119, 2013.
53.
PenchevaN, de GooijerMC, VisDJ, WesselsLFA, WurdingerT, van TellingenO, and BernardsR. Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness. Cell Rep, 20: 48–60, 2017.
54.
PeterkofskyB, TschankG, and LuedkeC. Iron-dependent uptake of ascorbate into isolated microsomes. Arch Biochem Biophys, 254: 282–289, 1987.
55.
PointerKB, ClarkPA, SchroederAB, SalamatMS, EliceiriKW, and KuoJS. Association of collagen architecture with glioblastoma patient survival. J Neurosurg, 126: 1812–1821, 2017.
56.
QuesnelA, KaragiannisGS, and FilippouPS. Extracellular proteolysis in glioblastoma progression and therapeutics. Biochim Biophys Acta Rev Cancer, 1874: 188428, 2020.
57.
RumseySC, KwonO, XuGW, BurantCF, SimpsonI, and LevineM. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem, 272: 18982–18989, 1997.
58.
RyszawyD, PudelekM, CatapanoJ, CiarachM, SetkowiczZ, KondurackaE, MadejaZ, and CzyzJ. High doses of sodium ascorbate interfere with the expansion of glioblastoma multiforme cells in vitro and in vivo. Life Sci, 232: 116657, 2019.
59.
SeligerC, MeyerAL, RennerK, LeidgensV, MoeckelS, JachnikB, DettmerK, TischlerU, GerthoferV, RauerL, UhlM, ProescholdtM, BogdahnU, RiemenschneiderMJ, OefnerPJ, KreutzM, Vollmann-ZwerenzA, and HauP. Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-beta2. Cell Cycle, 15: 1755–1766, 2016.
60.
Smith-CortinezN, FagundesRR, GomezV, KongD, de WaartDR, HeegsmaJ, SydorS, OlingaP, de MeijerVE, TaylorCT, BankR, PaulusmaCC, and FaberKN. Collagen release by human hepatic stellate cells requires vitamin C and is efficiently blocked by hydroxylase inhibition. FASEB J, 35: e21219, 2021.
61.
StraumeO, ChappuisPO, SalvesenHB, HalvorsenOJ, HaukaasSA, GoffinJR, BeginLR, FoulkesWD, and AkslenLA. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res, 62: 6808–6811, 2002.
62.
SunH, GuoD, SuY, YuD, WangQ, WangT, ZhouQ, RanX, and ZouZ. Hyperplasia of pericytes is one of the main characteristics of microvascular architecture in malignant glioma. PLoS One, 9: e114246, 2014.
63.
SunX, JohnsonJ, and St JohnJC. Global DNA methylation synergistically regulates the nuclear and mitochondrial genomes in glioblastoma cells. Nucleic Acids Res, 46: 5977–5995, 2018.
TelangS, ClemAL, EatonJW, and ChesneyJ. Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia, 9: 47–56, 2007.
66.
ThulPJ, AkessonL, WikingM, MahdessianD, GeladakiA, Ait BlalH, AlmT, AsplundA, BjorkL, BreckelsLM, BackstromA, DanielssonF, FagerbergL, FallJ, GattoL, GnannC, HoberS, HjelmareM, JohanssonF, LeeS, LindskogC, MulderJ, MulveyCM, NilssonP, OksvoldP, RockbergJ, SchuttenR, SchwenkJM, SivertssonA, SjostedtE, SkogsM, StadlerC, SullivanDP, TegelH, WinsnesC, ZhangC, ZwahlenM, MardinogluA, PontenF, von FeilitzenK, LilleyKS, UhlenM, and LundbergE. A subcellular map of the human proteome. Science, 356: eaal3321, 2017.
67.
TomerR, YeL, HsuehB, and DeisserothK. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat Protoc, 9: 1682–1697, 2014.
68.
TsaiHF, ChangYC, LiCH, ChanMH, ChenCL, TsaiWC, and HsiaoM. Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodeling. Cell Death Discov, 7: 313, 2021.
69.
UhlenM, ZhangC, LeeS, SjostedtE, FagerbergL, BidkhoriG, BenfeitasR, ArifM, LiuZ, EdforsF, SanliK, von FeilitzenK, OksvoldP, LundbergE, HoberS, NilssonP, MattssonJ, SchwenkJM, BrunnstromH, GlimeliusB, SjoblomT, EdqvistPH, DjureinovicD, MickeP, LindskogC, MardinogluA, and PontenF. A pathology atlas of the human cancer transcriptome. Science, 357: eaan2507, 2017.
70.
UlloaV, Garcia-RoblesM, MartinezF, SalazarK, ReinickeK, PerezF, GodoyDF, GodoyAS, and NualartF. Human choroid plexus papilloma cells efficiently transport glucose and vitamin C. J Neurochem, 127: 403–414, 2013.
71.
Vollmann-ZwerenzA, LeidgensV, FelicielloG, KleinCA, and HauP. Tumor cell invasion in glioblastoma. Int J Mol Sci, 21: 1932, 2020.
72.
WangH, LiuZ, LiA, WangJ, LiuJ, LiuB, LianX, ZhangB, PangB, LiuL, and GaoY. COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma. Exp Ther Med, 22: 1224, 2021.
73.
XiaoQ, JiangY, LiuQ, YueJ, LiuC, ZhaoX, QiaoY, JiH, ChenJ, and GeG. Minor Type IV Collagen alpha5 Chain Promotes Cancer Progression through Discoidin Domain Receptor-1. PLoS Genet, 11: e1005249, 2015.
YunJ, MullarkyE, LuC, BoschKN, KavalierA, RiveraK, RoperJ, ChioII, GiannopoulouEG, RagoC, MuleyA, AsaraJM, PaikJ, ElementoO, ChenZ, PappinDJ, DowLE, PapadopoulosN, GrossSS, and CantleyLC. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science, 350: 1391–1396, 2015.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
